Back
Skechers USA 10K Form
Buy
63
SKX
Skechers USA
Last Price:
$67.69
Seasonality Move:
13.97%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-03 | 10Q | SKX/Skechers USA Quarterly |
2023-11-08 | 10Q | SKX/Skechers USA Quarterly |
2023-08-04 | 10Q | SKX/Skechers USA Quarterly |
2023-05-05 | 10Q | SKX/Skechers USA Quarterly |
2022-11-04 | 10Q | SKX/Skechers USA Quarterly |
2022-08-05 | 10Q | SKX/Skechers USA Quarterly |
Receive SKX News And Ratings
See the #1 stock for the next 7 days that we like better than SKX
SKX Financial Statistics
Sales & Book Value
Annual Sales: | $8B |
---|---|
Cash Flow: | $-153.6M |
Price / Cash Flow: | 26.26 |
Annual Sales: | $28.87 |
Price / Book: | 2.35 |
Profitability
EPS (TTM): | 4.06000 |
---|---|
Net Income (TTM): | $627.3M |
Gross Margin: | $4.2B |
Return on Equity: | 13.77% |
Return on Assets: | 8.05% |
Skechers USA Earnings Forecast
Key Skechers USA Financial Ratios
-
The Gross Profit Margin over the past 26 years for SKX is 51.90%.
-
The Selling, General & Administrative Expenses for SKX have been equal to 42.09% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Interest Expense is 16.57% of Operating Income.
-
The Net Earning history of SKX is 6.82% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 17 years.
Skechers USA Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NYSE |
---|---|
Industry: | Textiles, Apparel & Luxury Goods |
Sector: | Consumer Discretionary |
Current Symbol: | SKX |
CUSIP: | 830566 |
Website: | skechers.com |
Debt
Debt-to-Equity Ratio: | 0.14 |
---|---|
Current Ratio: | 1.96 |
Quick Ratio: | 1.15 |
Price-to-Earnings
Trailing P/E Ratio: | 19.41 |
---|---|
Forward P/E Ratio: | 13.77 |
SKX Technical Analysis vs Fundamental Analysis
Buy
63
Skechers USA (SKX)
is a Buy
Is Skechers USA a Buy or a Sell?
-
Skechers USA stock is rated a BuyThe current Skechers USA [SKX] share price is $67.73. The Score for SKX is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.